Company / Operating Cash Flow per Share
Pfizer Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$2.05
FY2025
5-year range
$2.05 / $5.71
FY2021-FY2025
Trend
-7.8%
vs FY2024
Sector context
#39 of 212
Health Care
What the data says
Pfizer's operating cash flow per share of $2.05 is higher than 82% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $2.05 in FY2025 to $5.71 in FY2023.
Based on SEC 10-K filings.
2.05 in FY2025 with a 5-year CAGR of -3.2%. Top quartile in the Health Care sector.
Declined from $5.71 to $2.05 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -7.1%
- 5-Year CAGR
- -3.2%
- 10-Year CAGR
- -
Sector benchmark
+113.9% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 7.8% year-over-year.
- Ranks #39 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.05 | -7.8% |
| FY2024 | $2.22 | -61.1% |
| FY2023 | $5.71 | +123.2% |
| FY2022 | $2.56 | +15.3% |
| FY2021 | $2.22 | -8.0% |
| FY2020 | $2.41 | +16.0% |
| FY2019 | $2.08 | -21.0% |
| FY2018 | $2.63 | +12.0% |
| FY2017 | $2.35 | -11.7% |
| FY2016 | $2.66 | +24.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026